COSTA, Rafael Barroso Mendonça. Ayahuasca: uma experiência estética. Dissertação (Mestrado) – Universidade Federal Fluminense, Instituto de Ciências Humanas e Filosofia, Departamento de Psicologia, 2009.

LABATE, Beatriz Caiuby; ROSE, Isabel Santana de; SANTOS, Rafael Guimarães dos. Religiões ayahuasqueiras: um balanço bibliográfico. Campinas: Editora Mercado de Letras/Fapesp, 2008.

LABATE, B.C., SANTOS, R.G., ANDERSON, B., MERCANTEe, M., BARBOSA, P.C.R. Considerações sobre o tratamento da dependência por meio da ayahuasca. Núcleo de Estudos Interdisciplinares sobre Psicoativos (NEIP), 2009. Disponível em: www.neip.info.

LIRA, Wagner Lins. Os trajetos do êxtase dissidente no fluxo cognitivo entre homens, folhas, encantos e cipós: uma etnografia ayahuasqueira nordestina/ Wagner Lins Lira. – Dissertação (mestrado) – Universidade Federal de Pernambuco. CFCH. Antropologia, 2009.

GOMES, Marcelo Bolshaw. O Hermeneuta – Uma introdução ao estudo de Si. Dissertação de mestrado em Ciências Sociais. Natal: UFRN, 1997.

LIEVEGOED, Bernard. Fases da Vida – crise e desenvolvimento da individualidade. São Paulo: Editora Antroposófica, 1994.

MCKENNA, T. ‘Caos, Criatividade e o retorno do Sagrado – triálogos nas fronteiras do Ocidente’ (em conjunto com Ralph Abraham e Rupert Sheldrake) São Paulo: Cultrix/Pensamento, 1994.

METZNER, Ralph. Ayahuasca – Human Consciousness and the Spirit of Nature. Thunder’s Mouth Press, New York, 1999. Tradução Márcia Frazão, Rio de Janeiro: Gryphus, 2002.

MIKISZ, José Eliézer. A arte visionária e a Ayahuasca: Representações Visuais de Espirais e Vórtices Inspiradas nos Estados Não Ordinários de Consciência (ENOC). UFSC, 2009.

SHANON, Benny. A ayahuasca e o estudo da mente in: LABATE B. & SENA ARAÚJO W. (diretto da), O uso ritual da ayahuasca, 2002a pp. 631-659.

_______ O conteúdo das visões da Ayahuasca. Revista Mana, Out 2003, vol.9, n.2, p.109-152.

STRASSMAN, Richard. DMT: the spirit molecule: a doctor’s revolutionary research into the biology. Rochester: Park Street Press, InnerTraditions, 2001.Aranha C, Travaine G, Correa MA. Aspectos botânicos e taxonômicos das plantas Banisteriopsis sp e Psychotria sp. 1º Congresso em Saúde. Centro de Estudos Médicos – União do Vegetal; 1991 Maio 30-Jun 02; São Paulo, Brasil.

Barker SA, Littlefield-Chaubaud MA, David, C. Distribution of the hallucinogens N,N-dimethyltryptamine and 5-methoxyN,N-dimethyltryptamine in rat brain following intraperitoneal injection: application of a new solid-phase extraction LCAPcI-MS-MS isotope dilution method. J Chromatogr B 2001;751(1):37-47.

Blackledge RD, Taylor CM. Psychotria Viridis – A Botanical Source of Dimethyltryptamine (DMT). Microgram J. 2003; 1(1):18-22.

Brito GS. Farmacologia humana da hoasca (chá preparado de plantas alucinógenas usado em contexto ritual no Brasil). In: Labate BC. O uso ritual da ayahuasca. Campinas: Mercado de Letras Edições e Livraria; 2004. p.623-71.

Callaway JC, Airasksinen MM, Mckenna DJ, Brito GS, Grob CS. Platelet serotonin uptake sites increase in drinkers of ayahuasca. Psychopharmacology 1994; 116(1):385-7.

Callaway JC, Raymon LP, Hearn WL, Mckenna DJ, Grob,CS, Brito GS, Mash DC. Quantitation of N,Ndimethyltryptamine and harmala alkaloids in human plasma after oral dosing with ayahuasca. J Anal Toxicol. 1996;20(6):492-7.

Callaway JC, Grob CS, Ayahuasca preparations and serotonin reuptake inhibitors: a potential combination for severe adverse interactions. J Psychoactive Drugs 1998;30(4):367-9.

Callaway JC, Mckenna DJ, Grob CS, Brito GS, Raymon LP, Poland RE, et al. Pharmacokinetics of Hoasca alkaloids in healthy humans. J Ethnopharmacol. 1999;65(1):243-56.

Callaway JC, Grob CS, Mckenna DJ, Nichols DE, Shulgin A, Tupper KW. A demand for clarity regarding a case report on the ingestion of 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in an Ayahuasca preparation. J Anal Toxicol. 2006;29(1):406-7.

Carlini EA. Plants and central nervous system. Pharmacol Biochem Behav. 2003;75:501-12.

Cazenave SOS. Banisteriopsis caapi: ação alucinógena e uso ritual. Rev Psquiatr Clin. 2000;7(1):1-6.

Chauí M. Brasil: Mito fundador e sociedade autoritária. São Paulo: Fundação Perseu Abramo, 2000. 104p

Conselho Nacional Anti-Drogas. Resolução n.4, de 04 de novembro de 2004. Diário Oficial da União. Brasília (DF); 2004.

Costa, M.C.M., Figueiredo, M.C., Cazenave, S.O.S. Ayahuasca: Uma abordagem toxicológica do uso ritualístico. Rev Psquiatr Clin. 2005;32(6):310-8.

Cunningham, N. Hallucinogenic plants of abuse. Emerg Med Australas. 2008;20: 167-74.

Da Silveira DX, Grob CS, De Rios MD, Lopez E, Alonso LK, Tacla C, et al. Ayahuasca in adolescence: a preliminary psychiatric assessment. J Psychoactive Drugs 2005;37(2):129-33.

Doering-Silveira E, Lopez E, Grob CS, De Rios MD, Alonso LK, Tacla C, et al. Ayahuasca in adolescence: a neuropsychological assessment. J Psychoactive Drugs 2005;37(2):123-8.

Doering-Silveira E, Grob CS, De Rios MD, Lopez E, Alonso LK, Tacla C, et al. Report on psychoactive drug use among adolescents using ayahuasca within a religious context. J Psychoactive Drugs 2005a;37(2):141-4.

Franzen F, Gross H. Tryptamine, N,N-dimethyltryptamine, N,N-dimethyl-5-hydroxytryptamine and 5- methoxytryptamine in human blood and urine. Nature 1965;21(1):84-93.

Freedland CS, Mansbach RS. Behavioral profile of constituents in ayahuasca, an Amazonian psychoactive plant mixture. Drug Alcohol Depend. 1999; 54(1):183-94.

Gable RS. Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids. Addiction 2007;102(1):24-34.

Gambelunghe C, Aroni K, Rossi R, Moretti L, Bacci M. Identification of N,N-dimethyltryptamine and β-carbolines in psychotropic ayahuasca beverage. Biomed Chromatogr. 2008;22(1):1056-9.

Goulart SL. O contexto de surgimento do culto do Santo Daime: formação da comunidade e do calendário ritual. In: Labate BC. O uso ritual da ayahuasca. Campinas: Mercado de Letras Edições e Livraria; 2004. p.277-301.

Grob CS, Mckenna DJ, Callaway JC, Brito GS, Neves ES, Oberlaender G, et al. Human Psychopharmacology Of Hoasca, A Plant Hallucinogen Used in Ritual Context in Brazil. J Nerv Ment Dis. 1996;184(2):86-94.

Goodman, L.S; Gilman, A. (eds.). As bases farmacológicas da terapêutica. 11.ed. Rio de Janeiro: Ed McGraw-Hill, 2007. 1848p.

Halpern JH, Pope HGJr. Do hallucinogens cause residual neuropsychological toxicity? Drug Alcohol Depend. 1999;53(3):247-56.

Jacob MS, Presti DE. Endogenous psychoactive tryptamines reconsidered: an anxiolytic role for dimethyltryptamine. Med Hypotheses 2005;64(1):930-7.

Labate BC. A literatura brasileira sobre as religiões ayahuasqueiras. In: Labate BC. O uso ritual da ayahuasca. Campinas: Mercado de Letras Edições e Livraria; 2004. p.231-73.

Labigaline EJ. O uso de Ayahuasca em um contexto religioso por ex-dependentes de álcool. [Dissertação] São Paulo: Escola Paulista de Medicina, UNIFESP; 1998.

Laing RR, Siegel JA. Hallucinogens: A forensic drug handbook. Boston: Academic Press; 2003. 290p.

Liwszyc GE, Vuori E, Rasanen I, Issakainen J. Daime – A ritual herbal potion. J Ethnopharmacol. 1992;36:91-2.

Luna LE. Vegetalismo:Shamanism among the mestizo population of the Peruvian Amazon. J Ethnopharmacol. 1986;11(1):123-33.

Mckenna, D, Towers, GHN, Abbott, F. Monoamino Oxidase inhibitors in South American Hallucinogenic Plants: Tryptamine and β-Carboline constituents of Ayahuasca. J Ethnopharmacol. 1984;10(1):195-223.

Mckenna D. Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges. Pharmacol Ther. 2004;102(1):111-29.

Nichols DE. Hallucinogens. Pharmacol Ther. 2004 101(2):131-81.

Ott J. Ayahuasca Analogues: Pangæan Entheogens. Washington: Natural Products Books Co.; 1994. 127p.

Pires APS, Oliveira CDR, Moura S, Dorr FA., Silva WA, Yonamine M. Gás Chromatographic Analysis of dimethyltryptamine and β-carboline alkaloids in ayahuasca, in Amazonian psychoactive plant beverage. J Phytochem Anal. 2009;20(2):149-53.

Pomilio AB, Vitale AA, Ciprian-Ollivier J, CetkovichBakmas M, Gómez R, Vázquez G. Ayahoasca: an experimental psychosis that mirrors the transmethylation hypothesis of schizophrenia. J Ethnopharmacol. 1999;65(1):29-51.

Riba J, Rodríguez-Fornells A, Urbano G, Morte A, Antonijoan R, Montero M, Callaway JC, et al. Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers. Psycopharmacology 2001;154(1):85-95.

Riba J, Valle M, Urbano G, Yritia M, Morte A, Barbanoj MJ. Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excrection, and pharmacokinetics. J Pharmacol Exp Ther. 2003;306(1):73-83.

Santos, R.G., Moraes, C.C., Holanda, A. Ayahuasca e Redução do Uso Abusivo de Psicoativos: Eficácia Terapêutica? Psicol Teor Pesqui. 2006;22(3):363-70.

Shannon B. Os conteúdos das visões da Ayahuasca. MANA 2003;9(2):109-52.

Sklerov J, Levine B, Moore KA, King T, Fowler D. A fatal intoxication following the ingestion of 5-methoxy-N,Ndimethyltryptamine in an ayahuasca preparation. J Anal Toxicol. 2005;29(1):838-41.

Strassman RJ, Qualls CR. Dose-response study of N,Ndimethyltryptamine in humans. I. Neuroendocrine, autonomic, and cardiovascular effects. Arch Gen Psychiatry 1994;51(2):85-97.

Strassman RJ, Qualls CR, Uhlenhuth EH, Kellner R. Doseresponse study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale. Arch Gen Psychiatry 1994;51(2):98-104.

Stuckey DE, Lawson R, Luna LE. EEG gamma coherence and other correlates of subjective reports during ayahuasca experiences. J Psychoactive Drugs 2005;37(2):163-78.

Thompson AC, Nicollier GF, Pope DF, Indolealkylamines of Desmanthus illinoensis and their growth inhibition activity. J Agric Food Chem. 1987;35(1):301-5.

Tupper, KW, Entheogens and existential intelligence: The use of plant teachers as cognitive tools. Can J Contin Med Educ. 2002;27(4):499-516.

Tupper, KW, The globalization of ayahuasca: Harm reduction or benefit maximization? Int J Drug Policy 2008;19(4):297-303.

Vorce SP, Sklerov JH. A general screening and confirmation approach to the analysis of designer tryptamines and phenethylamines in blood and urine using GC-EI-MS and HPLC-electrospray-MS. J Anal Toxicol. 2004;28(6):407-10.

Yritia M, Riba J, Ortuño J, Ramirez A, Castillo A, Alfaro Y, et al. Determination of N,N-dimethyltryptamine and β-carboline alkaloids in human plasma following oral administration of Ayahuasca. J Chromatogr B Analyt Technol Biomed Life Sci. 2002;779(1):271-81.